Clindamycin phosphate: Difference between revisions
Gerald Chi (talk | contribs) (Created page with "__NOTOC__") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Clindamycin phosphate}} | |||
{{CMG}}; {{AE}} {{AK}} | |||
'''''For patient information, click <u>[[Clindamycin phosphate (patient information)|here]]</u>'''''. | |||
==Overview== | |||
Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel). | |||
==Category== | |||
[[Lincosamides]] | |||
==US Brand Names== | |||
CLEOCIN PHOSPHATE®, EVOCLIN®, CLEOCIN T®, CLEOCIN DERM®, CLINDA GEL®, CLINDAMAX® | |||
==FDA Package Insert== | |||
''' [[Clindamycin phosphate description|Description]]''' | |||
'''| [[Clindamycin phosphate clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[Clindamycin phosphate microbiology|Microbiology]]''' | |||
'''| [[Clindamycin phosphate indications and usage|Indications and Usage]]''' | |||
'''| [[Clindamycin phosphate contraindications|Contraindications]]''' | |||
'''| [[Clindamycin phosphate warnings|Warnings]]''' | |||
'''| [[Clindamycin phosphate precautions|Precautions]]''' | |||
'''| [[Clindamycin phosphate adverse reactions|Adverse Reactions]]''' | |||
'''| [[Clindamycin phosphate overdosage|Overdosage]]''' | |||
'''| [[Clindamycin phosphate dosage and administration|Dosage and Administration]]''' | |||
'''| [[Clindamycin phosphate how supplied|How Supplied]]''' | |||
'''| [[Clindamycin phosphate labels and packages|Labels and Packages]]''' | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] | |||
Latest revision as of 19:22, 9 January 2014
| Clindamycin phosphate |
|---|
| CLEOCIN PHOSPHATE®, EVOCLIN®, CLEOCIN T®, CLEOCIN DERM®, CLINDA GEL®, CLINDAMAX® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information, click here.
Overview
Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel).
Category
US Brand Names
CLEOCIN PHOSPHATE®, EVOCLIN®, CLEOCIN T®, CLEOCIN DERM®, CLINDA GEL®, CLINDAMAX®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Dosage and Administration | How Supplied | Labels and Packages